P3 AD Adult Combo TCS
Research payments
$620,854
Through program year 2023, $620,854 in research payments was reported against P3 AD Adult Combo TCS, across 48 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $620,854 | 48 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Tharp Brandon, FL Named on 2 payments
- Colin Ruff Leawood, KS Named on 2 payments
- Robert Szalewski Lincoln, NE Named on 2 payments
- So Yeon Paek Dallas, TX Named on 2 payments
- Paradi Mirmirani Vallejo, CA Named on 2 payments
- Dale Mohar Kerrville, TX Named on 2 payments
- Lawrence Parish Philadelphia, PA Named on 2 payments
- Satkirin Khalsa Albuquerque, NM Named on 1 payment
- Scott Fretzin Indianapolis, IN Named on 1 payment
- Christofer Buatti Auburn Hills, MI Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.